RecruitingNot ApplicableNCT03900910

Gastric Cancer Prevention for Indigenous Peoples

A Gastric Cancer Prevention Program for Aboriginal People Living in the Remote Areas

Sponsor

National Taiwan University Hospital

Enrollment

50,000 participants

Start Date

Jan 1, 2018

Study Type

INTERVENTIONAL

Conditions

Gastric Cancer

Summary

The incidence of gastric cancer in local indigenous peoples is higher than the non-Indigenous counterpart in Taiwan. How to design an effective prevention strategy for gastric cancer is of importance. The present study aimed to identify the causes that may account for the health inequalities, allowing generation of a plan of action on the whole population scale.

Eligibility

Min Age: 20 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying ways to prevent stomach cancer in Indigenous communities, likely by treating a common bacterial infection called H. pylori that is a known risk factor. You may be eligible if: you are between 20 and 60 years old; you are mentally able to understand and sign the consent form; and you can communicate with the study team. You may NOT be eligible if: you are pregnant; or you have a serious illness that would prevent safe participation. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERGastric cancer prevention

Participants will receive the 13C-urea breath test and those with test positive will further receive H. pylori eradication treatment.

OTHERExecution of the program

Screening program is audited by the standardized quality indicators, including the participation rate, the positivity rate, the referral-to-treatment rate, and the eradication rate .